Castration Resistant Prostatic Neoplasms Completed Phase Trials for Radium Ra-223 (DB12813)

Also known as: Prostate Neoplasms, Castration-resistant / Castration-Resistant Prostatic Neoplasms / Prostatic Neoplasms, Castration-Resistant

Indication	Status	Phase
DBCOND0129140 (Castration Resistant Prostatic Neoplasms)	Completed	Not Available

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT03563014	A Local Retrospective Observational Study to Evaluate the Treatment Patterns of mCRPC Patients in Belgium Treated With Radium-223		Radium Ra 223 dichloride (DB08913) Radium Ra-223 (DB12813)